Meridian Bioscience has introduced its new Air-Dryable Direct RNA/DNA qPCR Blood Mix which has been designed for the development of molecular diagnostic assays that are stable at room temperature.

The new blood mix enables the direct detection of RNA from whole blood samples and is compatible with air-drying in an oven. It also maintains high activity and sensitivity.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The diagnostic assays developed with this blood mix directly amplify RNA from crude whole blood, serum or plasma.

Meridian noted that qPCR has the ability to screen directly from blood samples.

This enables quick and sensitive detection of viral infections, including HIV, HBV or HCV, as well as bacterial infections, hereditary diseases and forensic analyses.

The air-dryable technology enables fast, simple and low-cost oven-drying procedures and replaces the need for lyophilisation.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This makes the new blood mix ideal for developing cost-effective, sensitive and stable molecular diagnostic assays.

Meridian global life science commercial operations vice-president Diane Szydel said: “The Air-Dryable Direct RNA/DNA qPCR Blood Mix provides a diagnostic developer with a ready to use master mix that has already addressed all the complex inhibitors present in blood, allowing for the development of simpler and faster assays.

“In addition, Meridian’s air-dryable technology overcomes the time and cost associated with cold storage or lyophilisation, allowing manufacturers full control of their entire manufacturing workflow.”

The new Air-Dryable Direct RNA/DNA qPCR Blood Mix can also be used on crude samples, eliminating the need for an extraction step.

It uses specialised enzymes as well as an advanced buffer formulation which is pre-optimised specifically for whole blood, serum and plasma.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact